Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Significant Increase in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 33,100 shares, an increase of 294.0% from the October 15th total of 8,400 shares. Based on an average trading volume of 48,800 shares, the short-interest ratio is presently 0.7 days.

Ocean Biomedical Stock Performance

Shares of OCEAW stock traded up $0.01 during trading hours on Tuesday, hitting $0.05. 4,175 shares of the company were exchanged, compared to its average volume of 41,181. Ocean Biomedical has a fifty-two week low of $0.02 and a fifty-two week high of $0.70. The company has a 50 day simple moving average of $0.04 and a two-hundred day simple moving average of $0.05.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.